Schnellzugriff

No journals followed

Browse journals

No saved papers

Feed Entdecken Trends Fragen Forschende

⌘K

Demystifying menopausal hormone therapy prescribing | Synapse

April 10, 2026

Demystifying menopausal hormone therapy prescribing

Key Points

To define appropriate practices for prescribing menopausal hormone therapy (MHT) in women experiencing menopause.
Conducted comprehensive assessments for women at menopause.
Evaluated risks and benefits of MHT.
Discussed lifestyle promotion alongside health screenings.
MHT can alleviate menopausal symptoms when no contraindications exist.
Systemic oestrogen is a core component of MHT.
Progestogen is recommended for women with an intact uterus.

Abstract

Women presenting at menopause should have a comprehensive assessment including updated health screening and promotion of a healthy lifestyle. MHT can be offered to women with symptoms in the absence of contraindications, following a discussion about risks and benefits. MHT comprises systemic oestrogen, and for those with an intact uterus, a progestogen.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Authors

K

Karen Magraith

C

Christina Jang

Journals

A

Australian Journal of General Practice

Actions

Institutions

The University of Queensland

University of Tasmania

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Cite this study

Magraith et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69d895206c1944d70ce06235 — DOI: https://doi.org/10.31128/ajgp-12-25-7923